Oracle chairman Larry Ellison has announced that AI will soon develop customised mRNA vaccine against cancer for every individual within 48 hours.

Oracle Chairman Larry Ellison highlighted AI's potential to revolutionize healthcare with early cancer detection and personalized vaccines. President Donald Trump announced a $500 billion private ...

MRNA) was among the notable gainers on Wednesday after Oracle (NYSE:ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of messenger RNA-based cancer vaccines.

CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure cancer. We’ve all heard such blusterous aspirational hype before, to be sure ...

At the launch of Stargate Project, Oracle's Ellison said that AI could assist in identifying the cancer fragments early ...

Ellison told ... and using AI to look at the blood test, you can find the cancers that are actually seriously threatening the person. You can make that vaccine, that mRNA vaccine, you can make ...

Oracle founder Larry Ellison said the massive artificial ... "And you can make that vaccine, that mRNA vaccine, you can make that robotically again using AI in about 48 hours." ...

Billionaire Larry Ellison’s backing of Stargate ... them against that cancer. That mRNA vaccine, you can make that robotically, again using AI, in about 48 hours.” The Ellison family ...

Bryan Johnson highlights Larry Ellison's views on AI revolutionizing healthcare, particularly in cancer detection, treatment, and vaccine development. Larry Ellison mentions the construction of ...

The latest guidance reduction was the second time in the last six months that the firm has revised its forecast in a negative ...

Larry Ellison unveiled plans for an AI-driven cancer vaccine system that could deliver personalized treatments within 48 hours.

CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure cancer. We’ve all heard such blusterous aspirational hype before ...